Key result
Endovascular strategies provide a safe and effective alternative to anticoagulants in high-bleeding-risk AF patients.
Why the study?
Endovascular strategies for thromboembolism prevention are gaining popularity in AF patients with contraindications to oral anticoagulants or high bleeding risk, warranting a review of preventive strategies.
Do endovascular strategies prevent thromboembolic events in patients with atrial fibrillation compared to anticoagulant therapy?
Do endovascular strategies prevent thromboembolic events in patients with atrial fibrillation compared to anticoagulant therapy?
Endovascular strategies provide an effective and safe alternative to anticoagulant therapy for preventing thromboembolism in atrial fibrillation patients with high bleeding risk.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for endovascular options in high-bleeding-risk AF; leaves open need for randomized trials before practice change.
The article dwells upon the various strategies for prevention of thromboembolic events in patients with atrial fibrillation. The main focus is put on the endovascular strategies for prevention of tromboembolism. In recent years, the endovascular strategies for the prevention of thromboembolic events in patients with atrial fibrillation, who have contraindications to oral anticoagulant therapy, are increasingly gaining popularity and find evidence of its safety for the prevention of thromboembolism. The patients with AF with a high risk of bleeding is the most interesting category for studying. The large studies confirm the effectiveness of non-drug prevention of thromboembolic events as compared to the anticoagulant therapy in these patients.
No takes yet. Share an insight, caveat, or question.
Al-Ayyubi et al. (2018) conducted a review in Atrial fibrillation. Endovascular strategies vs. Anticoagulant therapy was evaluated on Thromboembolic events. Endovascular strategies for thromboembolism prevention are effective and safe alternatives to anticoagulant therapy in atrial fibrillation patients with high bleeding risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: